Revolution Medicines RVMD
Todd Cislini Jeffrey (Officer) plans to sell 908 RVMD shares, about $105,528
- Form
- 144
- Filed
- Importance
- Routine
- Accession
- 0001950047-26-000611
- Approximate sale date: Jan 21, 2026
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Shares acquired by: Restricted Stock Units
- 10b5-1 plan adopted: Mar 13, 2025
Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.
Similar companies
Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.
- Biomarin Pharmaceutical BMRN public float $6.7B, Jun 30, 2025
- Jazz Pharmaceuticals JAZZ public float $6.3B, Jun 30, 2025
- Corcept Therapeutics CORT public float $6.1B, Jun 30, 2025
- Repligen RGEN public float $6.0B, Jun 30, 2025
- Madrigal Pharmaceuticals MDGL public float $5.6B, Jun 30, 2025
